OneChain Immunotherapeutics
PrivateLast Round
Grant
Feb 29, 2024
Total Funding Raised
$14.91M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
OneChain Immunotherapeutics is a biotechnology company that develops CAR-T therapies for the treatment of oncological diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OneChain Immunotherapeutics Comparables
Compare OneChain Immunotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Wugen | 83% | |
| Gyala Therapeutics | 83% | |
| PersonGen BioTherapeutics | 79% | |
OneChain Immunotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 29, 2024 | ||||
| Pre Seed | Jun 22, 2023 | ||||
| Grant | Feb 23, 2023 | ||||
| Seed | Jul 20, 2020 |
Key People
Founding team and executive leadership
OneChain Immunotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| CDTI Innvierte | Seed |
| Nara Capital | Pre Seed |
| Clave Capital | Pre Seed |
| Center for Technological Development and Innovation | Pre Seed, Seed |
| Invivo Partners | Pre Seed, Seed |
| Josep Carreras Leukaemia Foundation | Pre Seed, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
Monthly visitors grew 419% MoM, from 165 to 857.
- Feb 23, 2023
$2.65M grant from the European Innovation Council.
OneChain Immunotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about OneChain Immunotherapeutics's valuation, stock price, and market status.